Exagen inc. announces proposed public offering of common stock

Carlsbad, calif., may 07, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced that it has commenced an underwritten public offering of shares of its common stock.
XGN Ratings Summary
XGN Quant Ranking